Tongxinluo capsule can effectively reduce myocardial ischemic attack.
Coronary heart disease refers to heart disease caused by atherosclerosis of the coronary artery, stenosis, or occlusion of the vascular lumen, resulting in myocardial ischemia, hypoxia, or necrosis, also known as ischemic heart disease.
To put it simply, if the heart is compared to a piece of “soil”, the coronary artery is the “river” that irrigates the soil, and coronary heart disease is coronary atherosclerosis-if the “river” is blocked and the soil is not irrigated, the soil of the heart will become “dead”. The common type of coronary heart disease is the familiar angina pectoris and myocardial infarction.
According to the statistics released by the World Health Organization (WHO), during the 20 years from 2000 to 2020, coronary heart disease was the leading cause of death in all mankind, accounting for 16% of the total deaths in the world. There are as many as 60 million patients with coronary heart disease in China. With the continuous improvement of material living standards, the incidence of coronary heart disease is increasing. Every 10 years after 40 years old, the prevalence rate will be doubled.
It can be said that coronary heart disease is the “number one killer” that threatens human health. Generally speaking, some patients will feel chest tightness, chest pain, palpitation, dyspnea, and so on before the onset of coronary heart disease. after being aware of physical abnormalities, these patients often seek help from doctors to escape.
On the contrary, some patients do not feel any warning before the onset of the disease, do not feel any discomfort before the attack, and do not even know that they are sick. This trait of coronary heart disease can easily explain why some people love to exercise and look very healthy, but suddenly fall to the ground and never stand up again.
There are three stages in the prevention of coronary heart disease, the first is to prevent the risk factors of coronary heart disease when there is no coronary heart disease, the second is to prevent further aggravation of coronary heart disease, and the third is to reduce the mortality of patients after the occurrence of acute myocardial infarction.
The primary prevention of coronary heart disease is mainly “prevention without disease”. The specific way is to change bad living habits, in addition to controlling hypertension, hyperlipidemia, hyperglycemia, and other risk factors, but also quit smoking, limit alcohol, adhere to aerobic exercise, maintain a happy mood, control their emotions, avoid losing their temper, and so on, these are the causes of coronary heart disease.
Secondary prevention is to help patients with early diagnosis, and early treatment, to avoid myocardial infarction, sudden death, and other serious complications. The specific method of operation is to use drugs with a scientific basis and preventive effect on the basis of primary prevention and in accordance with the requirements of doctors. In drug selection, traditional Chinese medicine Tongluo medicine has obvious advantages. Tongluo representative drug Tongxinluo capsule can protect heart health through blood protection, vascular protection, heart ischemic tissue protection, and other links, which is the basic drug for the prevention and treatment of coronary heart disease.
Tong Xin Luo ingredients contain five unique insect medicine ingredients, which have the effect of replenishing qi and activating blood circulation, dredging collaterals, and relieving pain. it has a good therapeutic effect on patients with severe angina pectoris of coronary heart disease. Studies carried out by China Medical University also show that Tongxinluo can effectively relieve vasospasm, improve carotid blood flow and vascular sensitivity to serotonin, and effectively treat coronary heart disease and angina pectoris.
It is reported that the research project “Construction of Venation Theory of Traditional Chinese Medicine and its Guidance for the Prevention and Treatment of Microvascular Diseases”, which takes Tongxinluo treatment of cardiovascular and cerebrovascular diseases as an important part, won the first prize for national scientific and technological progress in 2019, and its effectiveness and safety are guaranteed.
Tertiary prevention is generally for patients with angina pectoris and myocardial infarction to take active treatment to prevent and treat heart failure, embolism, arrhythmia, sudden death, and other serious complications. Hospitalization is generally needed at this stage, including measures to improve myocardial blood supply through active anticoagulation, thrombolysis, the active opening of the coronary artery, protection of myocardial drugs, and so on.
